Clinical Trials Directory

Trials / Completed

CompletedNCT02158065

Impact of "Telecoaching Program" on Physical Activity in Patients With COPD

A 3-month Multicenter Randomized Trial to Evaluate the Efficacy of a Physical Activity Promotion Program on the Experience of Physical Activity in Patients With COPD (Mr PAPP)

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
370 (actual)
Sponsor
KU Leuven · Academic / Other
Sex
All
Age
40 Years
Healthy volunteers
Not accepted

Summary

The purpose of this 3 month randomized intervention study is to investigate the additional effect of a physical activity telecoaching program on physical activity in patients with COPD, compared with usual care.

Detailed description

In this 3 month, randomized (1:1 ratio), parallel-group, multicenter trial, patients in both groups (control and coaching) will receive information and guidance on the benefits associated with increased physical activity in COPD patients and their health status. Patients in both groups will use two PROactive monitors (ActiGraph® and DynaPort®) and a PDA to complete the PROactive questionnaire. In addition to above, the patients in the coaching group will receive daily coaching by a semiautomated system and coaching by the investigator during study visits.

Conditions

Interventions

TypeNameDescription
OTHERCoaching programThe coaching program consists of a (1) Step counter used as a coaching activity monitor to collect number of steps walked by the patients and (2) the Linkcare System, a mobile phone or tablet PC placed in the patient's home to collect data from the step counter. The system will set a daily activity goal for the patient based on achieved activity levels which will be measured by the step counter. Patients will also receive feedback, motivational and educational messages and direct calls from the coaching team at each institution.

Timeline

Start date
2014-05-01
Primary completion
2015-03-01
Completion
2015-03-01
First posted
2014-06-06
Last updated
2015-05-01

Locations

6 sites across 5 countries: Belgium, Greece, Netherlands, Switzerland, United Kingdom

Source: ClinicalTrials.gov record NCT02158065. Inclusion in this directory is not an endorsement.